INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,596,000 | +47.1% | 100,000 | +316.7% | 0.48% | +11.0% |
Q2 2022 | $3,804,000 | +74.5% | 24,000 | -20.0% | 0.43% | +132.6% |
Q1 2022 | $2,180,000 | -78.3% | 30,000 | +3429.4% | 0.18% | -73.9% |
Q4 2021 | $10,050,000 | +17.1% | 850 | -98.7% | 0.70% | +38.0% |
Q3 2021 | $8,586,000 | -15.8% | 64,000 | +1.6% | 0.51% | -36.4% |
Q2 2021 | $10,200,000 | – | 63,000 | – | 0.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |